Musculoskeletal Imaging

What Is the Best First Imaging Study for a Superficial Soft Tissue Mass?

·
What Is the Best First Imaging Study for a Superficial Soft Tissue Mass?

It’s a common end-of-day primary care visit: a 45-year-old patient points to a new, palpable, and mobile lump on their forearm that they noticed a few weeks ago. It’s painless and feels rubbery, located just under the skin. While clinical suspicion points toward a benign cause like a lipoma, the diagnostic path isn’t complete without confirming the nature of the mass and ruling out less common but more serious possibilities. The immediate clinical question is what imaging, if any, to order first. This article provides a focused workflow for this exact scenario, guided by the American College of Radiology (ACR) Appropriateness Criteria, which rates ‘US area of interest’ as Usually Appropriate for the initial imaging of a superficial soft tissue mass.

Who Fits the ‘Superficial Soft Tissue Mass’ Clinical Scenario?

This guidance applies to a specific patient presentation: an adult or child with a palpable soft tissue mass that is clinically determined to be superficial. This means the mass is located within the skin or subcutaneous fat, above the deep investing fascia that encases the underlying muscles. This workflow is intended for the initial imaging evaluation where no prior studies have been performed for this specific concern.

Correctly identifying the patient for this scenario is crucial, as similar presentations follow different diagnostic pathways. This workflow does not apply if:

  • The mass is deep: If the mass is fixed, non-mobile, or located beneath the deep fascia (intramuscular or intermuscular), it falls under the ACR variant for a nonsuperficial (deep) soft tissue mass, which has a different risk profile and imaging algorithm.
  • Prior imaging was nondiagnostic: If the patient has already had a radiograph or ultrasound that failed to characterize the mass, the next step is guided by the variant for a nondiagnostic initial study.
  • There are clear signs of infection or acute trauma: A fluctuant, erythematous mass concerning for an abscess or a mass appearing immediately after significant trauma (hematoma) may be managed based on clinical findings, though ultrasound is often still used for confirmation.

The key distinction is a palpable, superficial lump of unknown etiology requiring a first-line imaging test for characterization.

What Diagnoses Are You Working Up in This Scenario?

When ordering initial imaging for a superficial soft tissue mass, the goal is to differentiate common, benign lesions from the rare but critical-to-identify malignant or indeterminate masses that require further management. The differential diagnosis drives the choice of imaging.

The most common cause by far is a lipoma, a benign tumor of mature fat cells. These are typically soft, mobile, and painless. Ultrasound is highly effective at identifying the characteristic echotexture of fat, often allowing for a definitive diagnosis that ends the diagnostic workup.

Another frequent finding is an epidermal inclusion cyst (also known as a sebaceous cyst). These arise from a blocked hair follicle and are filled with keratin. Ultrasound can often visualize the cyst’s well-defined borders and sometimes a characteristic punctum or tract extending to the skin surface, confirming the diagnosis.

Ganglion cysts are also common, particularly near joints like the wrist, hand, or foot. These are fluid-filled sacs connected to a joint capsule or tendon sheath. Ultrasound excels at demonstrating the simple, anechoic (black) fluid content and any connection to adjacent structures, providing a confident diagnosis.

While most superficial masses are benign, the workup must consider the possibility of malignancy. A soft tissue sarcoma is much less common in a superficial location compared to a deep one, but certain subtypes can occur here. The purpose of imaging is not necessarily to name the specific tumor type but to identify features suspicious for malignancy—such as large size, complex internal structure, vascularity, or invasion of adjacent tissues—that signal the need for further evaluation with MRI and subsequent biopsy.

Why Is Ultrasound the Recommended Study for This Presentation?

The ACR designates ‘US area of interest’ as Usually Appropriate because it is the ideal first-line modality for evaluating superficial structures, balancing diagnostic efficacy with safety and resource utilization.

Ultrasound offers excellent spatial resolution, allowing for detailed visualization of the mass’s size, shape, borders, and internal characteristics. It can reliably distinguish solid from cystic lesions, a fundamental first step in characterization. For many common benign lesions, such as simple cysts, ganglion cysts, and typical lipomas, the sonographic appearance is so characteristic that the diagnosis can be made with high confidence, and no further imaging is necessary. The addition of color Doppler allows for assessment of vascularity, which can help triage masses; highly vascular solid lesions are generally more concerning.

Critically, ultrasound involves no ionizing radiation (0 mSv) and, for this initial evaluation, does not require intravenous contrast. This makes it exceptionally safe for all patients, including children and pregnant individuals.

In contrast, other powerful imaging modalities are rated lower for this initial step:

  • MRI area of interest without and with IV contrast is rated Usually not appropriate. While MRI provides superior soft tissue contrast, it is a more expensive and less accessible resource. It is considered a problem-solving tool, best reserved for cases where ultrasound is indeterminate or shows features suspicious for malignancy. Ordering MRI first for a simple palpable lump is not a cost-effective or efficient use of resources.
  • CT area of interest with IV contrast is also Usually not appropriate. CT has lower intrinsic soft tissue contrast compared to both ultrasound and MRI for this application. Furthermore, it exposes the patient to ionizing radiation (dose varies by body part and protocol). It offers little to no advantage over ultrasound for the initial characterization of a superficial mass.

When ordering, providing clear clinical information is key. The request should specify “Ultrasound of the [location] soft tissue mass” and include details from the physical exam, such as size, location, mobility, and any associated symptoms. This ensures the sonographer can properly target the exam.

What’s Next After Ultrasound? Downstream Workflow

The results of the initial ultrasound will guide the subsequent clinical pathway. The report should categorize the finding, leading to one of several distinct downstream actions.

  • If the result is a definitive benign finding: For masses with the classic appearance of a simple cyst, ganglion cyst, or uncomplicated lipoma, the diagnostic workup is typically complete. The appropriate next step is clinical correlation and patient reassurance. No further imaging is required unless the mass changes or becomes symptomatic.
  • If the result is indeterminate or suspicious: This is the most important outcome to act on. If the ultrasound shows a solid mass that is not a typical lipoma, or if it has complex features (e.g., thick walls, internal debris, significant vascularity, indistinct margins), it is considered indeterminate. The next step in this situation is almost always a more advanced imaging study. This effectively moves the patient into a new clinical scenario: “Soft tissue mass. Nondiagnostic…ultrasound.” The recommended follow-up study is typically an MRI of the area without and with IV contrast to better characterize the lesion and define its extent prior to a potential biopsy.
  • If the result is negative: If the ultrasound does not identify a discrete mass corresponding to the palpable area of concern, the clinician should reconsider the physical exam findings. The palpable lump may represent normal anatomy, such as the edge of a muscle belly, a prominent lymph node, or a fascial plane. Clinical follow-up is warranted.

This structured approach ensures that resources are used efficiently, reserving advanced imaging like MRI for cases where it is truly needed to guide further management.

Pitfalls to Avoid (and When to Get Help)

Navigating the workup of a superficial soft tissue mass is generally straightforward, but several common pitfalls can lead to diagnostic delays or unnecessary testing.

First, avoid the temptation to order MRI as the initial test. While a powerful tool, it is not the appropriate first step for a simple, superficial mass. Starting with ultrasound is more efficient, cost-effective, and often provides a definitive answer without the need for more advanced imaging.

Second, do not dismiss a mass simply because it is superficial. While the vast majority are benign, a small percentage can be malignant. The purpose of the ultrasound is to systematically evaluate the mass and identify the few that require a more aggressive workup.

Third, ensure the imaging order contains adequate clinical information. A request that simply says “lump on arm” is less helpful than one that specifies “2 cm mobile, non-tender subcutaneous mass on the volar aspect of the mid-forearm.” Precise location and physical exam findings are critical for the sonographer and radiologist.

If an ultrasound report returns with indeterminate or suspicious features for malignancy, this is the primary trigger for escalation. The patient should be referred to a specialist with expertise in soft tissue tumors, such as an orthopedic or surgical oncologist, for further evaluation, which will likely include MRI followed by a biopsy.

Related ACR Topics and Tools

This article covers one specific scenario within the broader topic of Soft Tissue Masses. For a comprehensive overview of all related clinical variants, from deep masses to post-operative follow-up, please consult our parent guide. You can also use the tools below to explore adjacent scenarios, review imaging protocols, and discuss radiation dose with patients.

Frequently Asked Questions

Is a plain radiograph (X-ray) ever useful for a superficial soft tissue mass?

Yes, the ACR rates radiography of the area of interest as ‘Usually Appropriate.’ It is most useful when there is suspicion of underlying bone involvement, calcifications within the mass (seen in conditions like myositis ossificans or some sarcomas), or a retained foreign body. However, for most simple, palpable lumps where the primary question is the nature of the soft tissue itself, ultrasound provides more direct and detailed information.

What makes a soft tissue mass ‘superficial’ versus ‘deep’?

The key anatomical landmark is the deep fascia, a layer of connective tissue that encases the muscles. A mass is considered superficial if it is located entirely within the skin or subcutaneous fat, above this fascia. A deep mass is located beneath the fascia, often within or between muscles. This distinction is clinically important because deep-seated masses have a significantly higher likelihood of being malignant than superficial ones.

If the patient is a child, does the imaging recommendation change?

No, the primary recommendation for initial imaging remains the same. Ultrasound is particularly advantageous in pediatric patients because it is fast, dynamic, well-tolerated, and, most importantly, avoids the use of ionizing radiation. The ACR data confirms that US is ‘Usually Appropriate’ for pediatric patients in this scenario.

Why is contrast-enhanced ultrasound rated ‘Usually Not Appropriate’ for initial imaging?

While contrast-enhanced ultrasound (CEUS) is a specialized technique for assessing tissue vascularity, it is not necessary for the initial characterization of a routine superficial mass. Standard grayscale and color Doppler ultrasound are sufficient to diagnose most common benign lesions (like a lipoma or cyst) or to identify a mass as indeterminate and requiring further workup. CEUS is a problem-solving tool used in specific circumstances, not a first-line screening test.

What if the mass is painful? Does that change the initial imaging choice?

The presence of pain does not change the initial imaging choice; ultrasound remains the recommended first step. However, pain is a critical piece of clinical information that should be included in the imaging request. It can raise suspicion for inflammation, infection (abscess), nerve impingement, or rapid growth, prompting the radiologist to pay special attention to features that could explain the patient’s symptoms.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026